Veena Palle

Principal Biostatistician

Veena Palle is a Principal Biostatistician at Cytel, bringing over a decade of expertise in clinical trials within both pharmaceutical and contract research organizations. Her academic credentials include a Master of Public Health (MPH) in Biostatistics & Epidemiology, a Master of Science (MSc) in Psychology, and clinical experience in homeopathic medicine and surgery.

Veena specializes in Phase I to IV clinical trials across various therapeutic areas, including oncology, neurology, gastrointestinal diseases, and rare diseases. She plays a pivotal role in Integrated Summary of Safety/Efficacy (ISS/ISE) studies, providing statistical leadership and ensuring rigorous analysis.

Collaborating closely with Data Management, statistical programmers, and medical writers, Veena contributes to the development of Case Report Forms (CRFs), study protocols, Statistical Analysis Plans (SAPs), Tables, Listings, and Figures (TLF) shells, and Clinical Study Reports (CSRs). Her involvement extends to serving on Data Monitoring Committees (DMCs), where she offers independent oversight of interim safety and efficacy data to inform critical trial decisions.

Proficient in SAS and R, Veena leads statistical analyses while mentoring emerging statisticians. Her research contributions include poster presentations at the Society for Clinical Trials (SCT) on “Challenges in Carrying Out DMC ‘Black Box’ Programming” and at PHUSE on “Topline Considerations in Double-Blind Clinical Trials.”